Filing Details
- Accession Number:
- 0001127602-20-028125
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-11-04 16:39:01
- Reporting Period:
- 2020-11-02
- Accepted Time:
- 2020-11-04 16:39:01
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1110803 | Illumina Inc. | ILMN | Laboratory Analytical Instruments (3826) | 330804655 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1520943 | A Francis Desouza | 5200 Illumina Way San Diego CA 92122 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-11-02 | 283 | $297.40 | 68,557 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-11-02 | 566 | $298.44 | 67,991 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-11-02 | 585 | $299.55 | 67,406 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-11-02 | 465 | $300.56 | 66,941 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-11-02 | 477 | $301.68 | 66,464 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-11-02 | 624 | $302.68 | 65,840 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The sale was made pursuant to a 10b5-1 plan.
- Weighted average sale price representing 283 shares sold ranging from $296.81 to $297.80 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 566 shares sold ranging from $298 to $298.90 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 585 shares sold ranging from $299.04 to $300.01 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 465 shares sold ranging from $300.15 to $301 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 477 shares sold ranging from $301.24 to $302.23 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 624 shares sold ranging from $302.28 to $303.25 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
Billionaire Hedge Funds
